Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations

References

• Andrade SE, Gurwitz JH, Field TS. et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care 2004;10:481–61Andrade SE, Gurwitz JH, Field TS. et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care 2004;10:481–6
   PubMed Web of Science ®Google Scholar
• Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens (Greenwich) 2008; 10:20–62Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens (Greenwich) 2008; 10:20–6
   PubMed Web of Science ®Google Scholar
• Dusing R. Overcoming barriers to effective blood pressure control in patients with hypertension. Curr Med Res Opin 2006;22:1545–533Dusing R. Overcoming barriers to effective blood pressure control in patients with hypertension. Curr Med Res Opin 2006;22:1545–53
   PubMed Web of Science ®Google Scholar
• Gradman AH, Acevedo C. Evolving strategies for the use of combination therapy in hypertension. Curr Hypertens Rep 2002;4:343–94Gradman AH, Acevedo C. Evolving strategies for the use of combination therapy in hypertension. Curr Hypertens Rep 2002;4:343–9
   PubMed Web of Science ®Google Scholar
• Chalmers J. The importance of drug combinations for effective control of hypertension. Clin Exp Hypertens. 1999;21:875–845Chalmers J. The importance of drug combinations for effective control of hypertension. Clin Exp Hypertens. 1999;21:875–84
   PubMed Web of Science ®Google Scholar
• Frank J. Managing hypertension using combination therapy. Am Fam Physician 2008;77:1279–866Frank J. Managing hypertension using combination therapy. Am Fam Physician 2008;77:1279–86
   PubMed Web of Science ®Google Scholar
• White WB. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension. Blood Press Monit 2008;13:123–97White WB. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension. Blood Press Monit 2008;13:123–9
   PubMed Web of Science ®Google Scholar
• Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006;19:1190–68Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006;19:1190–6
   PubMed Web of Science ®Google Scholar
• Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006;296:2563–719Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006;296:2563–71
   PubMed Web of Science ®Google Scholar
• Brixner DI, Joish VN, Odera GM. et al. Effects of benefit design change across 5 disease states. Am J Manag Care 2007;13:370–610Brixner DI, Joish VN, Odera GM. et al. Effects of benefit design change across 5 disease states. Am J Manag Care 2007;13:370–6
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S. et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713–1911Bangalore S, Kamalakkannan G, Parkar S. et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713–19
   PubMed Web of Science ®Google Scholar
• Faulkner MA, Hilleman DE. Amlodipine/benazepril: fixed dose combination therapy for hypertension. Expert Opin Pharmacother 2001;2:165–7812Faulkner MA, Hilleman DE. Amlodipine/benazepril: fixed dose combination therapy for hypertension. Expert Opin Pharmacother 2001;2:165–78
   PubMedGoogle Scholar
• Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm 2007;64:1279–8313Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm 2007;64:1279–83
   PubMed Web of Science ®Google Scholar
• Taylor AA. Combination drug treatment of hypertension: have we come full circle? Curr Cardiol Rep 2004;6:421–614Taylor AA. Combination drug treatment of hypertension: have we come full circle? Curr Cardiol Rep 2004;6:421–6
   PubMedGoogle Scholar
• Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 2003;9:324–3215Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 2003;9:324–32
   PubMedGoogle Scholar
• Sokol MC, McGuigan KA, Verbrugge RR. et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521–3016Sokol MC, McGuigan KA, Verbrugge RR. et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521–30
   PubMed Web of Science ®Google Scholar
• Berger M, Bingefors K, Hedblom E. et al. Health care cost, quality, and outcomes: ISPOR Book of Terms, 1st edn. Lawrenceville, NJ: ISPOR, 200317Berger M, Bingefors K, Hedblom E. et al. Health care cost, quality, and outcomes: ISPOR Book of Terms, 1st edn. Lawrenceville, NJ: ISPOR, 2003
   Google Scholar
• Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28:(9);1411–24; discussion 141018Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28:(9);1411–24; discussion 1410
   PubMed Web of Science ®Google Scholar
• Allemann Y, Fraile B, Lambert M. et al. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens (Greenwich) 2008;10:185–9419Allemann Y, Fraile B, Lambert M. et al. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens (Greenwich) 2008;10:185–94
   PubMed Web of Science ®Google Scholar
• Brixner DI, Jackson KC, Oberg B. et al. Factors influencing compliance with combination antihypertensive pharmacotherapy in a large US database. Value Health 2007; 10:A43220Brixner DI, Jackson KC, Oberg B. et al. Factors influencing compliance with combination antihypertensive pharmacotherapy in a large US database. Value Health 2007; 10:A432
   Google Scholar
• Chobanian AV, Bakris GL, Black HR. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–5221Chobanian AV, Bakris GL, Black HR. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–52
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–9722Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–97
   PubMed Web of Science ®Google Scholar
• Weir MR, Maibach EW, Bakris GL. et al. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med 2000;160:481–9023Weir MR, Maibach EW, Bakris GL. et al. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med 2000;160:481–90
   PubMed Web of Science ®Google Scholar
• Zyczynski TM, Coyne KS. Hypertension and current issues in compliance and patient outcomes. Curr Hypertens Rep 2000; 2:510–1424Zyczynski TM, Coyne KS. Hypertension and current issues in compliance and patient outcomes. Curr Hypertens Rep 2000; 2:510–14
   PubMedGoogle Scholar
• Muszbek N, Brixner D, Benedict A. et al. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int J Clin Pract 2008; 62:338–5125Muszbek N, Brixner D, Benedict A. et al. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int J Clin Pract 2008; 62:338–51
   PubMed Web of Science ®Google Scholar
• Halpern MT, Khan ZM, Schmier JK. et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47:1039–4826Halpern MT, Khan ZM, Schmier JK. et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47:1039–48
   PubMed Web of Science ®Google Scholar